Company · CIK 1836056
Ambrx Biopharma Cayman, Inc.
| CIK | 1836056 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | E9 |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-04-26 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271008 | 2023-03-30 | 2023-05-25 | 3 | |
| 333-266404 | 2022-07-29 | 2022-08-05 | 3 | |
| 333-256639 | 2021-05-28 | 2021-06-21 | 4 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-05-25 | 424B5Shelf takedown | 333-271008 | 0001193125-23-154202 |
| 2023-05-02 | EFFECTDeclared effective | 333-271008 | 9999999995-23-001234 |
| 2023-03-30 | S-3Shelf registered | 333-271008 | 0001193125-23-085776 |
| 2022-08-05 | EFFECTDeclared effective | 333-266404 | 9999999995-22-002279 |
| 2022-08-05 | 424B5Shelf takedown | 333-266404 | 0001193125-22-213604 |
| 2022-07-29 | F-3Shelf registered | 333-266404 | 0001193125-22-206626 |
| 2021-06-21 | 424B4Final prospectus | 333-256639 | 0001193125-21-194058 |
| 2021-06-17 | EFFECTDeclared effective | 333-256765 | 9999999995-21-002400 |
| 2021-06-17 | EFFECTDeclared effective | 333-256639 | 9999999995-21-002396 |
| 2021-06-14 | F-1/AAmendment | 333-256639 | 0001193125-21-189441 |
| 2021-05-28 | F-1Registration filed | 333-256639 | 0001193125-21-177104 |
| 2021-02-03 | DRSDraft made public | 377-04163 | 0000950123-21-000963 |